COVID is an international, peer-reviewed, open access journal on the study of coronaviruses, coronavirus-related diseases and global impact, published monthly online by MDPI.
  • Open Access— free to download, share, and reuse content. Authors receive recognition for their contribution when the paper is reused.
  • Rapid Publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 18 days after submission; acceptance to publication is undertaken in 4.5 days (median values for papers published in this journal in the second half of 2021).
  • Recognition of Reviewers: APC discount vouchers, optional signed peer review, and reviewer names published annually in the journal.
  • COVID is a companion journal of Viruses.
Add your e-mail address to receive forthcoming issues of this journal:
Topic in COVID, IJMS, Microorganisms, Viruses
Liquid-Liquid Phase Separation Editors-in-Chief: Maria João Amorim, Yohei Yamauchi
Deadline: 31 March 2022
Topic in COVID, IJERPH, Viruses
Wastewater-Based Epidemiology Editors-in-Chief: Matthew Scotch, Arvind Varsani
Deadline: 30 April 2022
Topic in COVID, Epidemiologia, Life, Sustainability, TropicalMed
Impact of COVID-19 Global Crisis on the Sustainable Development Goals Deadline: 31 July 2022
Topic in COVID, IJMS, Pathogens, Toxins, Viruses
Acute Respiratory Viruses Molecular Epidemiology Deadline: 31 December 2022
Special Issue in COVID
The Genetic Diversity, Evolution and Epidemiology of SARS-CoV-2 Guest Editor: Tohru Suzuki
Deadline: 1 March 2022
Special Issue in COVID
Application of Nanotechnology in the COVID-19 Pandemic Guest Editor: Mark J. Jackson
Deadline: 1 April 2022
Special Issue in COVID
Correlations between COVID-19 and the Immune System Guest Editor: Francesco Caruso
Deadline: 1 May 2022
Back to TopTop